DMAC - DiaMedica Therapeutics appoints Julie Krop as Chief Medical Officer
2025-08-06 08:48:48 ET
More on DiaMedica Therapeutics
- DiaMedica Therapeutics Inc. (DMAC) Q1 2025 Earnings Call Transcript
- DiaMedica Therapeutics raises $30 million in private placement
- DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia
- Seeking Alpha’s Quant Rating on DiaMedica Therapeutics
- Historical earnings data for DiaMedica Therapeutics